Kinetics of 3′-deoxy-3′-[F-18]fluorothymidine uptake and retention in dogs

Molecular Imaging and Biology

Volumn 4, Issue 1, 2002, Pages 83-89

  Shields, Anthony F ^a,d   Grierson, John R ^b   Muzik, Otto ^a   Stayanoff, Joseph C ^a   Lawhorn Crews, Jawana M ^a   Obradovich, Joyce E ^c   Mangner, Thomas J ^a  

^a DETROIT MEDICAL CENTER   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c Animal Cancer & Imaging Center Michigan   (United States)

^d KARMANOS CANCER INSTITUTE   (United States)

Author keywords

Fluorothymidine; PET; Thymidine; F 18 FLT

Indexed keywords

3' FLUOROTHYMIDINE; DNA; FLUORINE 18; THYMIDINE KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW; CELL PROLIFERATION; COMPARTMENT MODEL; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DNA SYNTHESIS; DRUG CLEARANCE; DRUG DEGRADATION; DRUG RETENTION; DRUG UPTAKE; ENZYME PHOSPHORYLATION; EXTRACTION; IMAGE QUALITY; NONHODGKIN LYMPHOMA; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SOFT TISSUE SARCOMA;

CANIS FAMILIARIS;

EID: 0036208025     PISSN: 15361632     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1095-0397(01)00070-X     Document Type: Article

References (13)

1. [11C]Thymidine and FDG to measure therapy response
2. Imaging Proliferation In Vivo with [F-18]FLT and Positron Emission Tomography
3. Regulation of human thymidine kinase during the cell cycle
4. Radiosynthesis of 3′-deoxy-3′-[(18)F]fluorothymidine: [(18)F]FLT for imaging of cellular proliferation in vivo
5. Development of a radiosynthesis for 3′-[F-18]fluoro-3′-deoxynucleosides
6. Expression of tissue isotope distribution
7. Comparisons of anti-human immunodeficiency virus activities, cellular transport, and plasma and intracellular pharmacokinetics of 3′-fluoro-3′-deoxythymidine and 3′-azido-3′-deoxythymidine
8. 14C]deoxyglucose method for the measurement of local cerebral glucose utilization: Theory, procedure, and normal values in the conscious and anesthetized albino rat
9. Tomographic measurements of local cerebral glucose metabolic rate in humans with (F-18) 2-fluoro-2-deoxy-D-glucose: Validation of method
10. Conditioning diagnostics: Collinearity and weak data in regression
11. A mathematical model for the analysis of cross-sectional brain glucose metabolism data in children
12. Pharmacokinetics of 3′-fluoro-3′-deoxythymidine and 3′-deoxy-2′,3′-didehydrothymidine in rhesus monkeys
13. Relationship between plasma concentrations of 3′-deoxy-3′-fluorothymidine (alovudine) and antiretroviral activity in two concentration-controlled trials